Gene Editing Tool Market AnalysisThe global gene editing tool market is on the cusp of a revolutionary expansion, projected to grow at an impressive CAGR of 18.4% from 2024 to 2034. Valued at USD 688.

Dr. David Lubarsky Nationally recognized healthcare leader returns to Westchester to lead innovation and expansion of patient ...

Technical leadership, predictive analytics, and personalized medicine can improve patient care. Here's what leaders in ...

The U.S. will need more than one million STEM workers in the next 10 years to stay competitive. Immigrants are critical to ...

We’ve been diligent in purpose and engaged in thoughtful discussions about our mission and vision: we intend to continue to engage the community in efforts to innovate and implement effective and ...

Tempus AI (NASDAQ: TEM) is a leader in precision medicine and artificial intelligence (AI) in the healthcare sector. Tempus ...

The new research from UC San Diego provides the most comprehensive look yet at how the rapid expansion of sports betting ...

Michael Restuccia, senior vice president and CIO of Philadelphia-based Penn Medicine, is preparing to retire after nearly two decades of leadership. In a Feb. 13 LinkedIn post, Mr. Restuccia announced ...

“If small biotech companies like ours are forced to scale back or shut down, it will not just be a loss for scientific ...

Healthcare's AI revolution is happening at two speeds: racing ahead with paperwork but proceeding cautiously with patient ...